SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (203)5/14/1999 2:31:00 PM
From: LLCF  Respond to of 555
 
On the face of it it looks like a strategic sales move, not a vote on the drug.... who was funding this SEPR of JNJ? (ie. was funding pulled, or has the market been fooled into thinking that?)...

DAK



To: scaram(o)uche who wrote (203)5/14/1999 2:39:00 PM
From: LLCF  Read Replies (1) | Respond to of 555
 
"In return J&J will recieive a royalty on SEPR's product sales".... doesn't sound like their pulling out to me! Sounds like the wild herd got steered right off a cliff.... they took someone out of 200K at 87.5....

DAK